Truway Health, Inc.
Rather than relying on a single abnormal vital sign, the study will examine how multiple physiologic signals change together over time and whether changes in the relationships among these signals provide useful information about impending clinical deterioration. Individual participant physiologic patterns may be characterized longitudinally to account for differences between individuals and changes within the same individual over time. The primary objective is to evaluate the predictive accuracy of multimodal digital biomarkers for protocol-defined acute clinical deterioration occurring within 72 hours. The study is observational and does not assign participants to an investigational treatment.
FUSION-72 (Multimodal Physiologic Signal Fusion for 72-Hour Prediction of Acute Clinical Deterioration) is a prospective, longitudinal, observational study designed to investigate multimodal digital biomarkers associated with acute clinical deterioration. The central scientific premise is that clinically meaningful deterioration may be preceded not only by an abnormal value in an individual physiologic parameter, but also by coordinated or discordant changes occurring across multiple physiologic, behavioral, and symptom domains. The study will collect longitudinal data from multiple digital a…
Inclusion Criteria: * Adults aged 18 through 90 years at enrollment. * Able to provide informed consent, or have a legally authorized representative provide consent when permitted by the applicable protocol and regulations. * Able and willing to participate in prospective longitudinal digital biomarker monitoring. * Able to use, or permit application of, study-authorized wearable or remote-monitoring technologies. * Able and willing to provide protocol-specified physiologic, behavioral, acoustic, and symptom data. * Expected to have sufficient follow-up to permit evaluation of the 72-hour pre…
Prospective collection and analysis of multimodal digital biomarkers derived from wearable and remote-monitoring technologies, including ECG, PPG, oxygen saturation, temperature, gait, sleep, voice, cough, and participant-reported symptom data. The monitoring is observational and does not direct or replace clinical care, does not assign treatment, and does not require modification of participants' usual medical management. Multimodal signals will be temporally aligned and evaluated for changes in inter-signal relationships associated with protocol-defined clinical deterioration occurring within the subsequent 72-hour prediction window.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.